Drug Approval | June 08, 2023
European Commission authorises GSK’s Arexvy for older adults
Authorisation will help protect adults 60 years of age and older in 30 European countries* from RSV disease for the first time
Authorisation will help protect adults 60 years of age and older in 30 European countries* from RSV disease for the first time
Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC)
The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Malaria is a life-threatening parasitic infection that is spread by the bites of mosquitoes carrying the Plasmodium parasite
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
Tavaborole Topical Solution, 5% had annual sales of US $3.1 million in the United States
Subscribe To Our Newsletter & Stay Updated
